Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 3:12:100356.
doi: 10.1016/j.rcsop.2023.100356. eCollection 2023 Dec.

Assessing suboxone access in community pharmacies: Secret shopper model

Affiliations

Assessing suboxone access in community pharmacies: Secret shopper model

Bethany A DiPaula et al. Explor Res Clin Soc Pharm. .

Abstract

Objective: To assess whether Maryland community pharmacies had Suboxone available for dispensing.

Methods: This cross-sectional study used a secret shopper model to contact public-facing community pharmacies in Maryland. The secret shopper, guided by a script, asked whether a prescription for Suboxone was available for the same or next day pick-up. A small convenience sample of pharmacies who did not have Suboxone available received an in-person visit to inquire about medication availability and dispensing barriers.

Results: After contacting 99% (n = 1046) of Maryland public-facing pharmacies, Suboxone was confirmed available for immediate pick-up in 31% (n = 326). The remaining did not have, would not disclose, or had limited access (existing patients or specific providers only). Significant differences in Suboxone availability were found for National Capital vs. Baltimore metro region and when pharmacist asked questions vs. no questions. Of the 11 pharmacy visits completed, 10 said they had Suboxone currently in stock, with one clarifying medication was for existing patients only.

Conclusion: About 69% of patients may face challenges when calling to find out whether they can obtain Suboxone in Maryland pharmacies. Better patient education and more thorough pharmacy-level investigation of system and workflow barriers could offer solutions.

Keywords: Buprenorphine/naloxone; Pharmacies; Pharmacists; Pharmacy; Suboxone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Script for pharmacy calls.
Fig. 2
Fig. 2
Flowchart of Pharmacy Selection.
Fig. 3
Fig. 3
Distribution of Maryland Pharmacies by Suboxone Availability.

Similar articles

Cited by

References

    1. The A.S.A.M. National Practice Guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S):1–91. - PubMed
    1. Ostrach B., Carpenter D., Cote L.P. DEA disconnect leads to buprenorphine bottlenecks. J Addict Med. 2021;15(4):272–275. doi: 10.1097/ADM.0000000000000762. - DOI - PubMed
    1. Carpenter D., Lambert K.V., Harless J.C., et al. North Carolina community pharmacists’ buprenorphine dispensing practices and attitudes. J Am Pharm Assoc. 2022;62(5):1606–1614. doi: 10.1016/j.japh.2022.04.019. - DOI - PubMed
    1. Trull G., Major E., Harless C., Zule W., Ostrach B., Carpenter D. Rural community pharmacist willingness to dispense Suboxone-a secret shopper investigation in South-Central Appalachia. Explor Res Clin Soc Pharm. 2021:4. doi: 10.1016/j.rcsop.2021.100082. - DOI - PMC - PubMed
    1. Hill L.G., Lorea L.J., Evoy K.E., et al. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA. Addiction. 2021;116(6):1505–1511. doi: 10.1111/add.15314. - DOI - PubMed

LinkOut - more resources